Teva To Appeal Decision Blocking Generic Prevacid

Law360, New York (April 1, 2008, 12:00 AM EDT) -- Teva Pharmaceutical Industries Ltd. is vowing to appeal a Delaware judge's decision that blocks the Israeli generics maker from entering the U.S. market for the TAP Pharmaceutical Products Inc.'s acid reflux treatment Prevacid until May 10, 2009.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware signed off Monday on a 46-page opinion saying that Teva had failed to prove by clear and convincing evidence that two patents asserted by the plaintiffs – U.S. Patent Numbers 4,628,098 and 5,045,321 – are...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.